ANDA 77064, held by Zydus Pharms USA. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 77064 (Metformin Hydrochloride), held by Zydus Pharms USA, was first approved by FDA on Apr 18, 2005, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 18, 2005 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride850MG · tablet;oral | Metformin Hydrochloride | Rx |
| Metformin Hydrochloride1GM · tablet;oral | Metformin Hydrochloride | Rx |
| Aug 11, 2026 | Supplement 30Labeling · Standard review | Approved | None posted |
| Jul 23, 2026 | Supplement 28Labeling · Standard review | Approved | None posted |
| Jul 23, 2026 | Supplement 29Labeling · Standard review | Approved | None posted |
| Apr 13, 2015 | Supplement 26Labeling · Standard review | Approved | None posted |
| May 19, 2011 | Supplement 15Labeling | Approved | None posted |
| Apr 12, 2010 | Supplement 8Labeling | Approved | None posted |
| Dec 28, 2009 | Supplement 16Labeling | Approved | None posted |
| Aug 11, 2009 | Supplement 12Labeling | Approved | None posted |
| Jan 28, 2008 | Supplement 9Labeling | Approved | None posted |
| Apr 18, 2005 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters